ATLAS / Macro Radar / Reporting / ACTU

ACTUATE THERAPEUTICS, INC. (ACTU) reporting calendar

ACTUATE THERAPEUTICS, INC. files periodic reports with the SEC as ACTU on Nasdaq. Atlas tracks 8 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
25 Jul 2026 – 5 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
14 May 2026
Reports on record
8

How this window is derived. Derived from this issuer's own filing history: 8 periods at a median 92-day cadence, filed a median 45 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open ACTU market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202614 May 202644 days0001683168-26-003909
10-K31 Dec 202526 Mar 202685 days0001683168-26-002257
10-Q30 Sep 202513 Nov 202544 days0001683168-25-008323
10-Q30 Jun 202514 Aug 202545 days0001683168-25-006159
10-Q31 Mar 202515 May 202545 days0001683168-25-003705
10-K31 Dec 202413 Mar 202572 days0001683168-25-001581
10-Q30 Sep 202413 Nov 202444 days0001683168-24-007971
10-Q30 Jun 202424 Sep 202486 days0001683168-24-006623

Source: SEC EDGAR company submissions for CIK 0001652935. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.